对于转移性激素敏感前列腺癌的当前治疗模式的进步
Shayan Smani1, Julien DuBois1, Ismail Ajjawi1
1Department of Urology, Yale School of Medicine, New Haven, CT 06520, USA.
Journal of clinical medicine
|April 26, 2025
概括
转移性荷尔蒙敏感前列腺癌 (mHSPCa) 治疗已经与双重和三重疗法等组合疗法取得了进展,显著改善了生存率. 精准医学和先进的成像是优化未来mHSPCa管理的关键.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医学科学 医学科学 医学科学
背景情况:
- 转移性激素敏感前列腺癌 (mHSPCa) 需要全身治疗,不可避免的进展到割抵抗.
- 治疗场景已经发展,结合了雄激素剥夺疗法 (ADT) 与雄激素受体信号抑制剂 (ARSIs) 或化疗.
研究的目的:
- 审查mHSPCa治疗策略的演变.
- 突出结合疗法和新兴技术在管理mHSPCa.的影响.
主要方法:
- 对具有里程碑意义的临床试验进行了审查 (CHAARTED,STAMPEDE,LATITUDE,ENZAMET,TITAN,ARASENS,PEACE-1).这些临床试验的研究结果包括:
- 讨论成像 (PSMA PET-CT) 和基因组分析方面的进展.
- 探索正在进行的新疗法,向药物和免疫疗法的研究.
主要成果:
- 结合疗法 (双重和三重) 结合ADT与ARSIs或化疗,显示出显著的整体生存益处.
- 三重疗法 (ADT,多塞塔克塞尔,ARSI) 显示出有效性,特别是在大体积转移性疾病中.
- 通过PSMA PET-CT改善疾病检测和通过基因组分析进行个性化策略.
结论:
- 组合疗法是对mHSPCa的标准护理,提供了改善的生存率.
- 基于精度的多学科方法,包括先进的诊断和新型疗法,对于未来的mHSPCa管理至关重要.
- 为了优化患者的治疗结果,平衡治疗疗效与耐受性至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K